These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 11505398)
1. Loss of motility-related protein 1 (MRP1/CD9) and integrin alpha3 expression in endometrial cancers. Miyamoto S; Maruyama A; Okugawa K; Akazawa K; Baba H; Maehara Y; Mekada E Cancer; 2001 Aug; 92(3):542-8. PubMed ID: 11505398 [TBL] [Abstract][Full Text] [Related]
2. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82. Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216 [TBL] [Abstract][Full Text] [Related]
3. Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung. Adachi M; Taki T; Huang C; Higashiyama M; Doi O; Tsuji T; Miyake M J Clin Oncol; 1998 Mar; 16(3):1060-7. PubMed ID: 9508191 [TBL] [Abstract][Full Text] [Related]
4. Anti-CD9 monoclonal antibody-stimulated invasion of endometrial cancer cell lines in vitro: possible inhibitory effect of CD9 in endometrial cancer invasion. Park KR; Inoue T; Ueda M; Hirano T; Higuchi T; Konishi I; Fujiwara H; Fujii S Mol Hum Reprod; 2000 Aug; 6(8):719-25. PubMed ID: 10908282 [TBL] [Abstract][Full Text] [Related]
5. Motility related protein 1 (MRP1/CD9) expression in colon cancer. Mori M; Mimori K; Shiraishi T; Haraguchi M; Ueo H; Barnard GF; Akiyoshi T Clin Cancer Res; 1998 Jun; 4(6):1507-10. PubMed ID: 9626469 [TBL] [Abstract][Full Text] [Related]
6. CD9 is expressed on human endometrial epithelial cells in association with integrins alpha(6), alpha(3) and beta(1). Park KR; Inoue T; Ueda M; Hirano T; Higuchi T; Maeda M; Konishi I; Fujiwara H; Fujii S Mol Hum Reprod; 2000 Mar; 6(3):252-7. PubMed ID: 10694273 [TBL] [Abstract][Full Text] [Related]
7. CD9 is expressed in extravillous trophoblasts in association with integrin alpha3 and integrin alpha5. Hirano T; Higuchi T; Ueda M; Inoue T; Kataoka N; Maeda M; Fujiwara H; Fujii S Mol Hum Reprod; 1999 Feb; 5(2):162-7. PubMed ID: 10065872 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis. Higashiyama M; Doi O; Kodama K; Yokouchi H; Adachi M; Huang CL; Taki T; Kasugai T; Ishiguro S; Nakamori S; Miyake M Int J Cancer; 1997 Apr; 74(2):205-11. PubMed ID: 9133457 [TBL] [Abstract][Full Text] [Related]
9. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. Mitsuzuka K; Handa K; Satoh M; Arai Y; Hakomori S J Biol Chem; 2005 Oct; 280(42):35545-53. PubMed ID: 16103120 [TBL] [Abstract][Full Text] [Related]
10. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753 [TBL] [Abstract][Full Text] [Related]
11. CD9 is involved in invasion of human trophoblast-like choriocarcinoma cell line, BeWo cells. Hirano T; Higuchi T; Katsuragawa H; Inoue T; Kataoka N; Park KR; Ueda M; Maeda M; Fujiwara H; Fujii S Mol Hum Reprod; 1999 Feb; 5(2):168-74. PubMed ID: 10065873 [TBL] [Abstract][Full Text] [Related]
12. ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma. Nagata M; Noman AA; Suzuki K; Kurita H; Ohnishi M; Ohyama T; Kitamura N; Kobayashi T; Uematsu K; Takahashi K; Kodama N; Kawase T; Hoshina H; Ikeda N; Shingaki S; Takagi R BMC Cancer; 2013 Sep; 13():410. PubMed ID: 24006899 [TBL] [Abstract][Full Text] [Related]
13. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas. Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139 [TBL] [Abstract][Full Text] [Related]
14. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma. Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509 [TBL] [Abstract][Full Text] [Related]
15. CD9 is expressed on the cell surface of human granulosa cells and associated with integrin alpha6beta1. Takao Y; Fujiwara H; Yamada S; Hirano T; Maeda M; Fujii S; Ueda M Mol Hum Reprod; 1999 Apr; 5(4):303-10. PubMed ID: 10321801 [TBL] [Abstract][Full Text] [Related]
16. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Sho M; Adachi M; Taki T; Hashida H; Konishi T; Huang CL; Ikeda N; Nakajima Y; Kanehiro H; Hisanaga M; Nakano H; Miyake M Int J Cancer; 1998 Oct; 79(5):509-16. PubMed ID: 9761121 [TBL] [Abstract][Full Text] [Related]
17. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Gesierich S; Paret C; Hildebrand D; Weitz J; Zgraggen K; Schmitz-Winnenthal FH; Horejsi V; Yoshie O; Herlyn D; Ashman LK; Zöller M Clin Cancer Res; 2005 Apr; 11(8):2840-52. PubMed ID: 15837731 [TBL] [Abstract][Full Text] [Related]
18. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Huang CI; Kohno N; Ogawa E; Adachi M; Taki T; Miyake M Am J Pathol; 1998 Sep; 153(3):973-83. PubMed ID: 9736046 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of CUB domain containing protein expression in endometrioid adenocarcinoma. Mamat S; Ikeda J; Enomoto T; Ueda Y; Rahadiani N; Tian T; Wang Y; Qiu Y; Kimura T; Aozasa K; Morii E Oncol Rep; 2010 May; 23(5):1221-7. PubMed ID: 20372833 [TBL] [Abstract][Full Text] [Related]
20. Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma. Hirano C; Nagata M; Noman AA; Kitamura N; Ohnishi M; Ohyama T; Kobayashi T; Suzuki K; Yoshizawa M; Izumi N; Fujita H; Takagi R Int J Cancer; 2009 Jun; 124(12):2911-6. PubMed ID: 19330835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]